Form HLTH5816 Special Authority Request - Letermovir - British Columbia, Canada

Form HLTH5816 Special Authority Request - Letermovir is used in British Columbia, Canada for requesting special authority to access and receive coverage for the medication called Letermovir.

The Form HLTH5816 Special Authority Request for Letermovir in British Columbia, Canada is typically completed by the prescribing healthcare provider.

FAQ

Q: What is HLTH5816 Special Authority Request?
A: HLTH5816 Special Authority Request is a form used in British Columbia, Canada to request special authority for the medication Letermovir.

Q: What is Letermovir?
A: Letermovir is a medication used to prevent certain viral infections in patients who have undergone a stem cell transplant.

Q: Who can use the HLTH5816 Special Authority Request?
A: The HLTH5816 Special Authority Request is used by healthcare providers in British Columbia, Canada.

Q: What is the purpose of the HLTH5816 Special Authority Request?
A: The purpose of the HLTH5816 Special Authority Request is to seek approval for coverage of the medication Letermovir for eligible patients.

Q: Who is eligible for special authority approval for Letermovir?
A: Eligibility for special authority approval for Letermovir is determined by the Ministry of Health in British Columbia, Canada.